Proteasome inhibitor RE-sensitizing molecules for treatment of refractory multiple myeloma
Ended Cooperative Agreement Awarded Last action
- Award ID
- R41CA213488
- Recipient
-
Leukogene Therapeutics Inc. UEI DDD1BU62TM94
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $219,605
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Mt Pleasant, SC 29466, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$3,353 | |
| Original award | $222,958 |
Quick answers
Who received award R41CA213488?
R41CA213488 was awarded to Leukogene Therapeutics Inc. by National Institutes of Health (Department of Health and Human Services) on September 22, 2016.
How much is award R41CA213488 worth?
$219,605 has been obligated on R41CA213488.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award